Aspen Aerogels (ASPN)
(Delayed Data from NYSE)
$27.24 USD
+1.13 (4.33%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $27.25 +0.01 (0.04%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Aspen Aerogels, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 239 | 180 | 122 | 100 | 139 |
Cost Of Goods | 182 | 175 | 112 | 86 | 113 |
Gross Profit | 57 | 5 | 10 | 15 | 26 |
Selling & Adminstrative & Depr. & Amort Expenses | 106 | 84 | 51 | 36 | 40 |
Income After Depreciation & Amortization | -49 | -79 | -41 | -22 | -14 |
Non-Operating Income | 2 | 0 | 4 | 0 | 0 |
Interest Expense | -1 | 3 | 0 | 0 | 0 |
Pretax Income | -46 | -83 | -37 | -22 | -15 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -46 | -83 | -37 | -22 | -15 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -46 | -83 | -37 | -22 | -15 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -29 | -65 | -31 | -11 | -4 |
Depreciation & Amortization (Cash Flow) | 21 | 14 | 9 | 10 | 10 |
Income After Depreciation & Amortization | -49 | -79 | -41 | -22 | -14 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 69.44 | 39.36 | 30.43 | 26.38 | 24.10 |
Diluted EPS Before Non-Recurring Items | -0.66 | -2.10 | -1.22 | -0.83 | -0.60 |
Diluted Net EPS (GAAP) | -0.66 | -2.10 | -1.22 | -0.83 | -0.60 |
Fiscal Year end for Aspen Aerogels, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 94.50 | 84.22 | 60.76 | 48.16 |
Cost Of Goods | NA | 59.36 | 54.60 | 46.95 | 39.75 |
Gross Profit | NA | 35.14 | 29.62 | 13.81 | 8.41 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 32.71 | 28.24 | 28.45 | 25.45 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.43 | 1.38 | -14.64 | -17.04 |
Non-Operating Income | NA | -0.48 | -1.31 | 3.50 | 0.00 |
Interest Expense | NA | 3.04 | 0.59 | 1.94 | -1.62 |
Pretax Income | NA | -1.08 | -0.52 | -13.07 | -15.42 |
Income Taxes | NA | 0.76 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.84 | -0.52 | -13.07 | -15.42 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1.84 | -0.52 | -13.07 | -15.42 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 75.76 | 70.02 | 69.32 | 69.25 |
Diluted EPS Before Non-Recurring Items | NA | 0.01 | -0.01 | -0.19 | -0.22 |
Diluted Net EPS (GAAP) | NA | -0.02 | -0.01 | -0.19 | -0.22 |